carbidopa and Cancer of Prostate

carbidopa has been researched along with Cancer of Prostate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, H; Cox, ME; Fazli, L; Fukumoto, T; Ghaidi, F; Gleave, ME; Plaa, N; Rennie, PS; Wafa, LA	1
Cheng, H; Fazli, L; Gleave, ME; Lamoureux, F; Rennie, PS; Thomas, C; Wafa, LA	1

Other Studies

2 other study(ies) available for carbidopa and Cancer of Prostate

Article	Year
Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression. International journal of cancer, 2012, Jun-15, Volume: 130, Issue:12 Topics: Animals; Apoptosis; Carbidopa; Cell Line, Tumor; Cell Proliferation; Disease Progression; Dopa Decarboxylase; Gene Expression Regulation, Neoplastic; Male; Mice; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Xenograft Model Antitumor Assays	2012
Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors. The Prostate, 2012, Jun-01, Volume: 72, Issue:8 Topics: Adenocarcinoma; Anilides; Animals; Antineoplastic Agents; Apoptosis; Carbidopa; Cell Line, Tumor; Cell Survival; Disease Progression; Dopamine Agents; Drug Synergism; Drug Therapy, Combination; Humans; In Vitro Techniques; Male; Mice; Mice, Nude; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds; Treatment Outcome; Xenograft Model Antitumor Assays	2012

Article

Year

Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression.

International journal of cancer, 2012, Jun-15, Volume: 130, Issue:12

Topics: Animals; Apoptosis; Carbidopa; Cell Line, Tumor; Cell Proliferation; Disease Progression; Dopa Decarboxylase; Gene Expression Regulation, Neoplastic; Male; Mice; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Messenger; Xenograft Model Antitumor Assays

2012

Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors.

The Prostate, 2012, Jun-01, Volume: 72, Issue:8

Topics: Adenocarcinoma; Anilides; Animals; Antineoplastic Agents; Apoptosis; Carbidopa; Cell Line, Tumor; Cell Survival; Disease Progression; Dopamine Agents; Drug Synergism; Drug Therapy, Combination; Humans; In Vitro Techniques; Male; Mice; Mice, Nude; Nitriles; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds; Treatment Outcome; Xenograft Model Antitumor Assays

2012